Abstract Randomized Controlled Trials (RCTs) are the “gold standard” for evaluating
treatment outcomes providing information on treatments “efficacy”. They are designed to test …

Real-world data (RWD) and real-world evidence (RWE) appear now as complementary to
traditional randomized controlled trials (RCT), that remain the gold standard of the evidence …

Abstract Background The English community pharmacy New Medicine Service (NMS)
significantly increases patient adherence to medicines, compared with normal practice. We …

We aimed to estimate the prevalence, healthcare costs and number of deaths among people
with chronic obstructive pulmonary disease (COPD) in England and Scotland 2011–2030 …

Background Worldwide, chronic obstructive pulmonary disease (COPD) is a highly prevalent
chronic lung disease with considerable clinical and socioeconomic impact. Pharmacologic …

Background: Asthma and chronic obstructive pulmonary disease (COPD) are incurable
diseases that impact quality-of-life. Objective: To summarize original research articles that …

Real-world data (RWD) is an umbrella term for different types of data that are not collected in
conventional randomised controlled trials. RWD in the healthcare sector comes from various …

Abstract Study Objectives: To estimate the health utility score and quality-adjusted life-years
(QALY) index of obstructive sleep apnea syndrome (OSAS) in patients over 1 y of …

Background: Big data and real-world data (RWD) have been increasingly used to measure
the effectiveness and costs in cost-effectiveness analysis (CEA). However, the …

Background: Endobronchial valve (EBV) therapy is an innovative treatment that has been
shown to be safe and effective in selected subgroups of patients with severe emphysema …